199 related articles for article (PubMed ID: 34498969)
1. Acetylcholinesterase and butyrylcholinesterase inhibition by nectriapyrone and tryptophol isolated from endophytic fungus
Dos Santos R; Morais-Urano RP; Marçal RM; Silva GH; Santos MFC
Nat Prod Res; 2022 Aug; 36(16):4153-4158. PubMed ID: 34498969
[TBL] [Abstract][Full Text] [Related]
2. IN VITRO ACETYLCHOLINESTERASE AND BUTYRYLCHOLINESTERASE INHIBITORY POTENTIALS OF JATROPHA GOSSYPIFOLIA PLANT EXTRACTS.
Saleem H; Ahmad I; Shahid MN; Gill MS; Nadeem MF; Mahmood W; Rashid I
Acta Pol Pharm; 2016; 73(2):419-23. PubMed ID: 27180434
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer's Disease.
Yu YF; Huang YD; Zhang C; Wu XN; Zhou Q; Wu D; Wu Y; Luo HB
ACS Chem Neurosci; 2017 Nov; 8(11):2522-2534. PubMed ID: 28783948
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant and Cholinesterase Inhibitory Activities of Ethyl Acetate Extract of
Rajmohamed MA; Natarajan S; Palanisamy P; Abdulkader AM; Govindaraju A
Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S437-S445. PubMed ID: 29142396
[TBL] [Abstract][Full Text] [Related]
5. Anticholinesterase and Antioxidant Activities of Natural Abietane Diterpenoids with Molecular Docking Studies.
Topçu G; Akdemir A; Kolak U; Öztürk M; Boğa M; Bahadori F; Çakmar SDH
Curr Alzheimer Res; 2020; 17(3):269-284. PubMed ID: 32329687
[TBL] [Abstract][Full Text] [Related]
6. Targeting acetylcholinesterase and butyrylcholinesterase in dementia.
Lane RM; Potkin SG; Enz A
Int J Neuropsychopharmacol; 2006 Feb; 9(1):101-24. PubMed ID: 16083515
[TBL] [Abstract][Full Text] [Related]
7. Aaptamine - a dual acetyl - and butyrylcholinesterase inhibitor as potential anti-Alzheimer's disease agent.
Miao S; He Q; Li C; Wu Y; Liu M; Chen Y; Qi S; Gong K
Pharm Biol; 2022 Dec; 60(1):1502-1510. PubMed ID: 35968601
[TBL] [Abstract][Full Text] [Related]
8. Dual inhibition of acetylcholinesterase and butyrylcholinesterase enzymes by allicin.
Kumar S
Indian J Pharmacol; 2015; 47(4):444-6. PubMed ID: 26288480
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of human cholinesterases by drugs used to treat Alzheimer disease.
Darvesh S; Walsh R; Kumar R; Caines A; Roberts S; Magee D; Rockwood K; Martin E
Alzheimer Dis Assoc Disord; 2003; 17(2):117-26. PubMed ID: 12794390
[TBL] [Abstract][Full Text] [Related]
10. A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase.
Greig NH; Utsuki T; Yu Q; Zhu X; Holloway HW; Perry T; Lee B; Ingram DK; Lahiri DK
Curr Med Res Opin; 2001; 17(3):159-65. PubMed ID: 11900310
[TBL] [Abstract][Full Text] [Related]
11. Lepidine B from Lepidium sativum Seeds as Multi-Functional Anti- Alzheimer's Disease Agent: In Vitro and In Silico Studies.
Talia S; Benarous K; Lamrani M; Yousfi M
Curr Comput Aided Drug Des; 2021; 17(3):360-377. PubMed ID: 32116197
[TBL] [Abstract][Full Text] [Related]
12. Phytochemical profiling and in vitro screening for anticholinesterase, antioxidant, antiglucosidase and neuroprotective effect of three traditional medicinal plants for Alzheimer's Disease and Diabetes Mellitus dual therapy.
Penumala M; Zinka RB; Shaik JB; Mallepalli SKR; Vadde R; Amooru DG
BMC Complement Altern Med; 2018 Mar; 18(1):77. PubMed ID: 29499679
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.
Giacobini E; Spiegel R; Enz A; Veroff AE; Cutler NR
J Neural Transm (Vienna); 2002 Jul; 109(7-8):1053-65. PubMed ID: 12111443
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
[TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase and butyrylcholinesterase inhibitory activities of antioxidant peptides obtained from enzymatic pea protein hydrolysates and their ultrafiltration peptide fractions.
Asen ND; Aluko RE
J Food Biochem; 2022 Nov; 46(11):e14289. PubMed ID: 35758753
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling.
Feng B; Li X; Xia J; Wu S
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):968-977. PubMed ID: 28718678
[TBL] [Abstract][Full Text] [Related]
17. Cholinesterase Inhibitors from an Endophytic Fungus
Hamed AA; El-Shiekh RA; Mohamed OG; Aboutabl EA; Fathy FI; Fawzy GA; Al-Taweel AM; Elsayed TR; Tripathi A; Al-Karmalawy AA
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985531
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and molecular docking studies of 5-trifluoromethoxy-2-indolinones as cholinesterase dual inhibitors.
Soylu-Eter Ö; Özsoy N; Karalı N
Future Med Chem; 2024 Apr; 16(7):623-645. PubMed ID: 38470247
[No Abstract] [Full Text] [Related]
19. The interactions of azure B, a metabolite of methylene blue, with acetylcholinesterase and butyrylcholinesterase.
Petzer A; Harvey BH; Petzer JP
Toxicol Appl Pharmacol; 2014 Feb; 274(3):488-93. PubMed ID: 24161345
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses.
Kamal MA; Shakil S; Nawaz MS; Yu QS; Tweedie D; Tan Y; Qu X; Greig NH
CNS Neurol Disord Drug Targets; 2017; 16(7):820-827. PubMed ID: 28176640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]